Abstract:Background: miR-500a-3p has been demonstrated to be involved in the development, progression and metastasis in several human cancers. Constitutive activation of JAK/STAT3 signaling pathway has been reported to play an important role in the development and progression of hepatocellular carcinoma (HCC).The purpose of this study was to determine the biological roles and clinical significance of miR-500a-3p in HCC and to identify whether miR-500a-3p has an effect on the activity of JAK/STAT3 signaling in HCC. Methods: miR-500a-3p expression was examined by real-time PCR in 8 paired HCC tissues and individual 120 HCC tissues respectively. Statistical analysis was performed to explore the clinical correlation between miR-500a-3p expression and clinicopathological features and overall and relapse-free survival in HCC patients. In vitro and in vivo assays were performed to investigate the biological roles of miR-500a-3p in HCC. The bioinformatics analysis, real-time PCR, western blot and luciferase reporter assay were performed to discern and examine the relationship between miR-500a-3p and its potential targets. Clinical correlation of miR-500a-3p with its targets was examined in HCC tissues. Results: miR-500a-3p is dramatically elevated in HCC tissues and cells and high expression of miR-500a-3p correlates with poor overall and relapse-free survival in HCC patients. Upregulating miR-500a-3p enhances, while silencing miR-500a-3p suppresses, the spheroid formation ability, fraction of side population and expression of cancer stem cell factors in vitro and tumorigenicity in vivo in HCC cells. Our findings further reveal miR-500a-3p promotes the cancer stem cell characteristics via targeting multiple negative regulators of JAK/STAT3 signaling pathway, including SOCS2, SOCS4 and PTPN11, leading to constitutive activation of STAT3 signaling. Moreover, the inhibitory effects of anti-miR-500a-3p on cancer stem cell phenotypes and activity of STAT3 signaling were reversed by silencing SOCS2, SOCS4 and PTPN11 in miR-500a-3p-downexpressing cells, respectively. Clinical correlation of miR-500a-3p with the targets was examined in human HCC tissues. Conclusion: our results uncover a novel mechanism by which miR-500a-3p promotes the stemness maintenance of cancer stem cell in HCC, suggesting that silencing miR-500a-3p may serve as a new therapeutic strategy in the treatment of hepatocellular carcinoma.

MicroRNA-520a-3p Induces Apoptosis in Lung Cancer Stem Cells Via Modulation of MAP3K2

Mir‑654‑3p Suppresses Cell Viability and Promotes Apoptosis by Targeting RASAL2 in Non‑small‑cell Lung Cancer.

MicroRNA-15a Induces Cell Apoptosis and Inhibits Metastasis by Targeting BCL2L2 in Non-Small Cell Lung Cancer

microRNA-520a-3p inhibits proliferation and cancer stem cell phenotype by targeting HOXD8 in non-small cell lung cancer.

MiRNA-195-5p Functions As a Tumor Suppressor and a Predictive of Poor Prognosis in Non-small Cell Lung Cancer by Directly Targeting CIAPIN1

Effect of miR-335 upregulation on the apoptosis and invasion of lung cancer cell A549 and H1299

Mir-145-5p Inhibits Epithelial-Mesenchymal Transition Via the JNK Signaling Pathway by Targeting MAP3K1 in Non-Small Cell Lung Cancer Cells.

MicroRNA-520e Inhibited the Migration and Invasion of Lung Cancer A549 Cells by Regulating Zinc Finger Protein 367

MicroRNA‑365b‑3p Represses the Proliferation and Promotes the Apoptosis of Non‑small Cell Lung Cancer Cells by Targeting PPP5C

Tumor Suppressor Mir-520A Inhibits Cell Growth by Negatively Regulating PI3K/AKT Signaling Pathway in Acute Myeloid Leukemia.

MicroRNA-17-5p Inhibits Proliferation and Triggers Apoptosis in Non-Small Cell Lung Cancer by Targeting Transforming Growth Factor Β Receptor 2.

miR-520b Promotes Breast Cancer Stemness Through Hippo/YAP Signaling Pathway.

Hypoxia‐induced Microrna‐301b Regulates Apoptosis by Targeting Bim in Lung Cancer

Effects of IncRNA PROX1-AS1 on Proliferation, Migration, Invasion and Apoptosis of Lung Cancer Cells by Regulating MiR-1305

Effect of Up-Regulating miR-519d on Proliferation and Apoptosis of Laryngeal Squamous Cell Carcinoma

Down-Regulation of TMPO-AS1 Induces Apoptosis in Lung Carcinoma Cells by Regulating miR-143-3p/CDK1 Axis

Effect of microRNA-135a on Cell Proliferation, Migration, Invasion, Apoptosis and Tumor Angiogenesis Through the IGF-1/PI3K/Akt Signaling Pathway in Non-Small Cell Lung Cancer

Mir-512-5p Induces Apoptosis and Inhibits Glycolysis by Targeting P21 in Non-Small Cell Lung Cancer Cells

Hsa-miR-139-5p inhibits proliferation and causes apoptosis associated with down-regulation of c-Met

miR-500a-3p promotes cancer stem cells properties via STAT3 pathway in human hepatocellular carcinoma

Downregulation of DNMT3A by miR-708-5p Inhibits Lung Cancer Stem Cell-like Phenotypes through Repressing Wnt/beta-catenin Signaling